Joseph A Crapotta, MD | |
363 Fremont St Ste 301, Battle Creek, MI 49017-3391 | |
(866) 435-8935 | |
Not Available |
Full Name | Joseph A Crapotta |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 39 Years |
Location | 363 Fremont St Ste 301, Battle Creek, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326070020 | NPI | - | NPPES |
1326070020 | Medicaid | MI | |
01532214 | Medicaid | NY |
Entity Name | All City Ophthalmology Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649209875 PECOS PAC ID: 0042122178 Enrollment ID: O20031105000589 |
News Archive
A new study reports the seroprevalence among schoolchildren in Zurich, Switzerland. Published on the preprint server medRxiv* in September 2020, this study contributes to the current discussion on how and when to reopen schools.
Genzyme Corporation today announced that it has entered into an asset purchase agreement under which Sekisui Chemical Co., Ltd. will acquire Genzyme's Diagnostic products business for $265 million in cash.
Lifeline Scientific (AIM: LSIC), the transplantation technology company, welcomes the publication in Experimental and Clinical Transplantation of the clinical study (‘Study'): "Hypothermic Machine Perfusion Permits Extended Cold Ischemia Times With Improved Early Graft Function."
Roche today announced that the U.S. Food and Drug Administration has approved the cobas KRAS Mutation Test for diagnostic use. The real-time PCR test is designed to identify KRAS mutations in tumor samples from metastatic colorectal cancer (mCRC) patients and aid clinicians in determining a therapeutic path for them.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Joseph A Crapotta, MD 850 W North St Ste 104, Jackson, MI 49202-3196 Ph: (664) 358-9358 | Joseph A Crapotta, MD 363 Fremont St Ste 301, Battle Creek, MI 49017-3391 Ph: (866) 435-8935 |
News Archive
A new study reports the seroprevalence among schoolchildren in Zurich, Switzerland. Published on the preprint server medRxiv* in September 2020, this study contributes to the current discussion on how and when to reopen schools.
Genzyme Corporation today announced that it has entered into an asset purchase agreement under which Sekisui Chemical Co., Ltd. will acquire Genzyme's Diagnostic products business for $265 million in cash.
Lifeline Scientific (AIM: LSIC), the transplantation technology company, welcomes the publication in Experimental and Clinical Transplantation of the clinical study (‘Study'): "Hypothermic Machine Perfusion Permits Extended Cold Ischemia Times With Improved Early Graft Function."
Roche today announced that the U.S. Food and Drug Administration has approved the cobas KRAS Mutation Test for diagnostic use. The real-time PCR test is designed to identify KRAS mutations in tumor samples from metastatic colorectal cancer (mCRC) patients and aid clinicians in determining a therapeutic path for them.
› Verified 7 days ago
Dr. Larry Marvin Vanderplas, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3600 Capital Ave Sw, Ste 203, Battle Creek, MI 49015 Phone: 269-979-6383 Fax: 269-979-6381 | |
Dr. Randall C Stout, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3600 Capital Ave Sw, Ste 203, Battle Creek, MI 49015 Phone: 269-979-6383 Fax: 269-979-6381 | |
Dr. Marie Burke, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3600 Capital Ave Sw Ste 203, Battle Creek, MI 49015 Phone: 269-979-6383 Fax: 269-979-6381 | |
James L Keller, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2845 Capital Ave Sw, Suite 202, Battle Creek, MI 49015 Phone: 269-979-6305 Fax: 269-979-6329 | |
Dr. James Edwin Macvicar, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1 Hiawatha Cove Trail, Battle Creek, MI 49015 Phone: 269-963-6130 |